This document introduces ZORBAX SB-CN column, including that it is the only acid-stable CN column and has unique selectivity.
This document presents a customer validation case study where Robert Ricker, an application chemist at Agilent Technologies, confirms that ZORBAX columns outperform competitive alternatives in separating analytes. A specific fax from January 1998 is cited as evidence of the column's ruggedness and superior performance against analogous Supelcosil columns.
The text highlights key features of the ZORBAX SB-CN column, noting it is the only acid-stable CN (Cyano) column available. It emphasizes the unique selectivity provided by this stationary phase for pharmaceutical applications.
ZORBAX SB-CN is highlighted as the only acid-stable CN column available.
The document states that the performance of Stable bond columns (ZORBAX) is superior to analogous Supelcosil columns.